C

Cutting Edge Research Group | Oklahoma City, OK

Research site

(Unclaimed)

Location

6613 North. Meridian Avenue, Oklahoma City, Oklahoma, United States of America

Site insights

Top conditions

Top treatments

Lurasidone

Brexpiprazole

Cariprazine

Dasotraline

Eszopiclone

Vilazodone

HYD

SPD489

Balovaptan

Divalproex

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 61 total trials

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder. (3112 Ped BPD)

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United S...

Enrolling

Bipolar I Disorder

Depression

Drug: Placebo

Drug: Cariprazine

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients who are experiencing major depressive episodes (MDEs)...

Enrolling

Bipolar Depression

Drug: Lumateperone

Drug: Placebo

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophren...

Enrolling

Autism Spectrum Disorder

Schizophrenia

Drug: Lumateperone